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Background: In patients withMarfan syndrome (MFS), increased aortic wall stiffeningmay lead to progressive
aortic dilatation. Aortic PulseWave Velocity (PWV), amarker of wall stiffness can be assessed regionally, using
in-plane multi-directional velocity-encoded MRI. This study examined the diagnostic accuracy of regional
PWV for prediction of regional aortic luminal growth during 2-year follow-up in MFS patients.
Methods: In twenty-one MFS patients (mean age 36±15 years, 11 male) regional PWV and aortic luminal areas
were assessed by 1.5 T MRI. At 2-year follow-up, the incidence of luminal growth, deﬁned as mean luminal diam-
eter increase >2 mm was determined for ﬁve aortic segments (S1, ascending aorta; S2, aortic arch; S3, thoracic
descending aorta, S4, supra-renal and S5, infra-renal abdominal aorta). Regional PWV at baseline was considered
increased when exceeding age-related normal PWV (healthy volunteers (n=26; mean age 30±10 years, 15
male)) by two standard-errors. Sensitivity and speciﬁcity of regional PWV-testing for prediction of regional luminal
growth were determined.
Results: Regional PWV at baseline was increased in 17 out of 102 segments (17%). Signiﬁcant luminal growth at
follow-up was reported in 14 segments (14%). The speciﬁcity of regional PWV-testing was ≥78% for all aortic
segments, sensitivity was ≤33%.
Conclusions: Regional PWV was signiﬁcantly increased in MFS patients as compared to healthy volunteers within
similar age range, in all aortic segments except the ascending aorta. Furthermore, regional PWV-assessment has
moderate to high speciﬁcity for predicting absence of regional aortic luminal growth for all aortic segments in
MFS patients.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Marfan syndrome (MFS) is an autosomal connective tissue disease
caused by mutations in the gene encoding for ﬁbrillin-1 [1]. In MFS pa-
tients, ﬁbrillin-1 deﬁciency leads to impaired aortic elasticity (i.e. aortic
stiffness), increased transforming growth factor beta (TGF-β) signalling
[2,3] and smooth muscle cells apoptosis, degrading the support of the
aorta [4]. Aneurysm formation is the result. Indeed, the leading causeds Heart Foundation (Project
iden University Medical Center,
31 71 5264858; fax: +31 71
Ltd. All rights reserved.of premature death inMFS patients is aortic dissection after progressive
dilatation due to the local increased aortic wall stiffness [5]. According-
ly, clinical management aims for prevention of aortic dissection by reg-
ular evaluation of local aortic diameter and screening for abnormal
luminal growth in combination with ß-blocker treatment to slow
down aortic growth [6–8]. However, many MFS patients even when
treated, develop eventually aortic dilatation and even dissection. Fur-
thermore, aortic dissection may also occur in non-dilated aortas [6].
Therefore, investigation of other risk factors, such as aortic stiffness, is
recommended for predicting progressive aortic dilatation [9–11].
A marker of aortic stiffness is the aortic pulse wave velocity
(PWV), deﬁned as the propagation speed of the systolic velocity
wave front through the aorta. PWV-assessment by magnetic reso-
nance imaging (MRI) is a well-validated method to non-invasively
quantify arterial stiffness [12]. Recently, an improved MRI-technique
2978 E.S.J. Kröner et al. / International Journal of Cardiology 167 (2013) 2977–2982with two-directional in-plane velocity-encoding (VE) covering the
whole aorta in a multi-slice volume scan has been introduced for
the assessment of regional and local PWV [13]. This approach results
in dense PWV-sampling at 200 points along the aorta centerline,
thereby enabling global, regional and local PWV-assessment [13]. It
is expected that in MFS patients, with local variability of disease man-
ifestation, PWV-assessment with in-plane VE MRI potentially allows
for the detection of subtle changes in local aortic stiffness and thereby
the identiﬁcation of areas at risk. To our knowledge, the predictive
value of regional aortic stiffness described by PWV, for luminal aortic
growth in MFS patients has not been reported before.
The purpose of the current study was therefore to investigate
whether increased regional PWV at baseline (increased with respect
to age-related normal values) can predict regional aortic luminal
growth at 2-year follow-up in patients with MFS.
2. Methods
2.1. Patient population and protocol
Twenty-one MFS patients and 26 healthy volunteers (without history of cardiac dis-
eases) were prospectively studied with MRI in our institution. Written informed consent
was obtained from each subject and the study protocol conformed to the Declaration of
Helsinki and was approved by the Medical Ethical Committee. MFS patients were eligible
for inclusion when 1) the diagnosis of MFS has been established according to the Ghent
criteria [14], 2) they had no history of aortic surgery and 3) signiﬁcant aortic valve or mi-
tral valve insufﬁciency was excluded by echocardiography. Patients were diagnosed with
MFS in specialized outpatient clinics in the Netherlands (Leiden University Medical Cen-
ter, Leiden, the Netherlands (n=18); AmsterdamUniversityMedical Center, Amsterdam,
the Netherlands (n=3)). Patients temporarily refrained from beta-adrenergic blocking
medication and were at least 24 hours without this medication prior to MRI.
All patients underwent baseline and follow-up MRI examination (median follow-
up: 24 months (25-75%: 23-25 months)) to assess both regional aortic stiffness
(PWV), by using velocity-encoded MRI and regional aortic lumen area, by using
contrast-enhanced magnetic resonance angiography (MRA). In addition, twenty-six
healthy volunteers were included to acquire age-related normal PWV-values. Of
note, the healthy volunteers underwent only the baseline velocity-encoded (VE) MRI
examination to acquire age-related normal PWV values and they did not undergo
MRA examination.
For patients, ﬁrst the regional PWV were compared against these age-related normal
values and were considered to be increased if PWV exceeded age-related normal values
by 2 standard errors of the regression coefﬁcients. Second, the incidence of regional lumi-
nal growth in the MFS patients, between baseline and follow-up MRI was assessed. Con-
secutively, the predictive value of PWV at baseline for regional luminal growth at
follow-up was analyzed.
2.1.1. MRI acquisition
MRIwas performedwith a 1.5 T scanner (Philips Intera, release 11 and 12; PhilipsMed-
ical Systems, Best, the Netherlands; pulsar gradient system with amplitude 33 mT/m,
100 mT/m/ms slew rate, and 0.33 ms rise time). Imaging sequences were previously de-
scribed [13]. In short, after acquisition of a series of thoracic survey images which were
used for planning purposes, a three-slice volume slab (covering a double-oblique sagittal
view of the aorta) was obtained with a steady-state free precession (SSFP) sequence and
used for planning the VE MRI acquisitions [13].
2.1.2. Pulse wave velocity
PWV was assessed by means of two consecutive multi-slice two-directional
in-plane VE MRI acquisitions of the three-slice double-oblique sagittal volume slab of
the aorta. Velocity-encoding was performed in phase-encoding (i.e., anterior-
posterior (AP)) direction and in frequency-encoding (i.e., feet-head (FH)) direction
consecutively. The velocity-sensitivity was set to 150 cm/s. The body coil was used
for signal reception. Scan parameters encompassed 60% rectangular ﬁeld-of-view
FOV 450×270 mm2, 10 mm slice thickness, echo time TE 2.4 ms, repetition time TR
4.3 ms, ﬂip angle α 10º, acquisition voxel size 3.5×2.1×10.0 mm3, sampling band-
width 495 Hz and number of signal averages NSA 2. Retrospective gating was
performed with maximal number of phases reconstructed. The true temporal resolu-
tion (TRes) amounted to 8.6 ms (equals 2×TR). Acquisition was performed with free
breathing and mean scan time of a single acquisition amounted to 7 minutes 8 seconds
at a typical heart rate of 65 bpm.
2.1.3. Contrast-enhanced magnetic resonance angiography
In addition, contrast-enhanced magnetic resonance angiography (CE-MRA) of the
full aorta was performed by ﬁrst-pass imaging of a 25 mL contrast bolus Dotarem
(Guerbet, Gorinchem, the Netherlands) with a molarity of 0.5 mmol/mL. Contrastwas intravenously injected in the basilic, brachial or cephalic vein at an infusion rate
of 2 mL/s, and subsequently ﬂushed by 20 mL saline at 2 mL/s, using Spectris
Powerinjector (Medrad, Warrendale, USA). Contrast arrival time for the CE-MRA acqui-
sition (i.e. the appropriate scan delay time after contrast injection) was obtained by
imaging a transection of the proximal descending aorta continuously for one minute
during injection of a 2 mL timing bolus, which was injected with the same infusion
rate and saline ﬂush. The contrast arrival time was determined by using region of inter-
est analysis of the aortic lumen, to produce a time-intensity curve and obtain the
time-to-peak arterial contrast enhancement. Consecutively the CE-MRA of the full
aorta was performed with 3D T1-weighted fast gradient-echo sequence (85% rectangu-
lar FOV 500×80 mm2, 50 slices of 1.6 mm slice thickness, TE 4.6 ms, TR 1.3 ms, α 40°,
acquisition voxel size 1.25×2.46×3.20 mm3, sampling bandwidth 238 Hz and NSA 1).
Breath-holding at end-expiration was performed.2.2. Image analysis
Regional PWV and aortic luminal area were obtained from MRI
data. MRI analysis of MFS patients with respect to the patient charac-
teristics was performed blinded. A schematic representation of image
acquisition and analysis in a MFS patient is provided in Fig. 1. The
aorta was divided into ﬁve segments (Fig. 1A); the ascending aorta
(S1), which included the aortic root, the tubular portion of the as-
cending aorta and extending to the brachiocephalic artery origin;
the aortic arch (S2), which begins at the origin of the brachiocephalic
artery, extending to the left common subclavian artery; the thoracic
descending aorta (S3) which begins at the left common subclavian ar-
tery extending to the level of the diaphragm; the suprarenal abdom-
inal aorta (S4) from the level of the diaphragm to the origin of the
renal arteries; the infrarenal abdominal aorta (S5). The aortic seg-
ments for CE-MRA (at both baseline and follow-up) and PWV-
analysis (at baseline) were registered manually by registration of
the aortic centerline that was calculated during PWV- and CE-MRA
image processing. Only after this image analysis was completed, re-
sults for PWV and CE-MRA analyses were combined.2.2.1. Regional pulse wave velocity
Regional PWV was obtained from the two-directional, three-slice
in-plane velocity-encoded MRI data using in-house developed MASS
software, as described [13] (Fig. 1D). The aorta was segmented in all
three double-oblique sagittal views and the aortic centerline was au-
tomatically deﬁned from this segmentation. Perpendicular to this
centerline, at 200 sampling positions along the aorta, equidistant
lines were automatically placed. Along each of these lines, the veloc-
ity was sampled and the maximal velocity per line was recorded,
resulting in the maximal velocity wave form (constructed from the
velocity components in AP and FH direction in each phase of the car-
diac cycle) of blood ﬂowing along the aortic centerline. Wave propa-
gation analysis was performed to determine the pulse wave arrival at
each sampling position automatically, by foot detection of the wave.
The diastolic ﬂow velocity was modeled as a horizontal line and the
upslope of the wave front was modeled by linear regression of 20%
to 80% of all values along the slope. The pulse wave arrival time was
then determined by the intersection of both lines. Regional PWV per
segment was obtained from the relation between pulse wave arrival
time versus sampling location along the aortic centerline. This rela-
tion was determined by linear regression. PWV was then deﬁned by
the inverse of the slope of this linear relation between pulse wave ar-
rival time and the sampling position. This regional PWV was obtained
for each of the ﬁve aortic segments (Fig. 1E).
Normal values of regional PWV per segment were determined
from the healthy volunteer data. The age-relation of these normal
values was determined by linear regression (PWV=A x Age+B).
Consecutively, regional PWV of the MFS patients were compared
against these age-related normal values. The PWV assessed in MFS
was considered increased if this value exceeded the predicted normal
PWV (predicted according to the age of the patient) with two
Fig. 1. Representation of image acquisition and analysis in a MFS patient. Regional aortic luminal area and regional PWV were obtained from MRI data. Fig. 1A. Maximum-
intensity-projection of contrast-enhanced (CE) MRA data of an MFS patient. Five aortic segments were evaluated: ascending aorta (S1), aortic arch (S2), thoracic descending aorta
(S3) suprarenal abdominal aorta (S4) and infrarenal abdominal aorta (S5). Fig. 1B. The CE-MRA image analysis was performed using in-house developed LAVA software with automated
centerline detection and 3D deformable modeling. Fig. 1C. From CE-MRA data, cross-sectional luminal area was determined at 200 equidistantly-spaced sample points along the aortic
centerline. For both baseline and 2-year follow-up, the mean lumen area per segment was determined. Fig. 1D. PWV was obtained from two-directional, three-slice in-plane
velocity-encoded MRI data using in-house developed MASS software, by calculating the relation between pulse wave arrival time at 200 equidistantly-spaced sample points along the
aortic centerline and the position of these sample points along the centerline (Fig. 1E). The centerline of PWV analysiswas registeredmanually to theMRA centerline, andMRA centerline
at baseline and follow-up were also manually registered. Regional PWV was determined for each of the ﬁve aortic segments.
Table 1
Characteristics of MFS patients.
Characteristics MFS Patients
(n=21)
Healthy volunteers
(n=26)
p-value
Demographics
Male/female 11 (52%) /10
(48%)
16 (62%) /10 (39%) 0.5
Age at baseline MRI (years) 36±15 30±10 0.12
Brachial blood pressure
(mmHg)
Systolic 124±11 122±15 0.6
Diastolic 73±9 71±11 0.5
Heart rate (beats/minute) 66±10 67±10 0.95
Height (cm) 187±10 177±10 0.003
Body surface area (m2) 2.11±0.27 1.9±0.2 0.005
Body mass index (kg/ m2) 25±5 23±3 0.2
Ectopia Lentis 8 (38%)
Mitral valve prolapse 9 (43%)
Aortic root diameter by
MRI (mm)
40.0±3.4
Genetic mutation 18 (86%)
Fibrillin-1 17 (81%)
Transforming growth factor-2
receptor
1 (5%)
ß -blocker use 14 (66%)
ACE inhibitors 5 (24%)
Data are presented as number (percentage) or asmean±standard deviation. Abbreviations:
MFS: Marfan syndrome; MRI: magnetic resonance imaging; ACE: Angiotensin converting
enzyme.
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PWV is increased if PWV>((A+2 x SEA) x AGE+(B+2 x SEB)).
2.2.2. Aortic luminal growth
From CE-MRA data in patients, the mean cross-sectional luminal
area per aortic segment was determined at baseline and at 2-year
follow-up (Fig. 1B.). Image analysis was performed using in-house
developed and validated LAVA software with automated 3D center-
line detection and automated segmentation using deformable tube
modeling [15]. The required user-interaction for centerline detection
and lumen segmentation was limited to the placement of start and
end point in the 3D data. Automated lumen segmentation resulted
in a tube ﬁt of the aorta. Next, the cross-sectional luminal area was
determined at 200 equidistantly-spaced positions along the center-
line (Fig. 1C.). When required, the lumen segmentation was corrected
manually on the cross-sectional view of the aorta. Image analysis
resulted in a mean luminal area per segment. Assuming a circular
shape, the mean diameter was calculated for each segment, both for
baseline and follow-up.
A mean aortic luminal diameter increase from baseline to follow-up
(2 years) of more than 2 mm was considered signiﬁcant growth. This
cut-off represents a substantial increase, based on typical MFS aortic
growth characteristics [16] and a comparable deﬁnition (mean aortic
diameter increase>1 mm/year) has been used previously [10].
2.2.3. Intra- and inter-observer analysis
Intra- and inter-observer analysis for repeated image analysis was
performed. Five patients were selected at random; one observer
performed image analysis twice (with inter-examination time more
than 6 months) and another observer repeated the analysis, blinded
to the results of the other observer. For each patient, baseline MRAand PWV-analysis was repeated. Regional aortic lumen area and
PWV were obtained, for aortic segments 2 to 5 (segment 1 was not
taken into account, as for this segment, no anatomical start point mark-
er was deﬁned), resulting in a total of 20 evaluable measurements.
Table 3
Linear regression analysis PWV in healthy volunteers per aortic segment: PWV=A x
Age+B.
Aortic Segment A±SE B±SE Pearson R
PWV S1 (m/s) 0.05±0.02 3.76±0.66 0.46 (p=0.017)
PWV S2 (m/s) -0.02±0.04 4.63±1.19 -0.09 (p=0.672)
PWV S3 (m/s) 0.06±0.02 3.12±0.55 0.57 (p=0.003)
PWV S4 (m/s) 0.06±0.02 3.39±0.55 0.55 (p=0.004)
PWV S5 (m/s) 0.06±0.03 3.39±0.95 0.39 (p=0.067)
Data are presented as mean±standard error (SE).
Abbreviations: PWV: Pulse Wave Velocity; SE: standard error; S1: ascending aorta; S2:
aortic arch; S3: thoracic descending aorta; S4: suprarenal abdominal aorta; S5:
infrarenal abdominal aorta.
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Continuous variables are expressed as mean±standard deviation
(SD). Parameters describing blood pressure (BP) and PWVwere com-
pared between MFS patients and healthy volunteers using unpaired
t-tests. For the healthy volunteers, linear regression analysis was
performed (PWV=A x Age+B) in each of the ﬁve aortic segments.
Age-related normal values were deﬁned from this data for each seg-
ment, with PWV within limits of 2 standard errors of the regression
coefﬁcients. In MFS patients, the incidence of increased PWV per
aorta segment was calculated as well as the incidence of aortic lumi-
nal growth over 2-year follow-up. In addition, sensitivity, speciﬁcity,
positive and negative predictive value of regional PWV-assessment
for predicting aorta luminal growth were calculated. Statistical analy-
sis was performed using SPSS v 18.0 (SPSS Inc., Chicago, IL).
3. Results
Twenty-one MFS patients (mean age: 36 years (min-max:
18-63 years)), diagnosed according to the Ghent criteria, were
evaluated [14]. Patient characteristics at the time of inclusion are
summarized in Table 1. Eleven patients (52%) were male and all pa-
tients were adults at time of inclusion. Marfan genetic mutations
were found in 18 patients (86%). Pathologic mutations in the
ﬁbrillin-1 gene were identiﬁed in 17 patients (81%), whereas in 1
patient (5%) a pathologic mutation in transforming-growth factor-
2 receptor was found. A positive family history for MFS was found
in 17 (81%) of the patients. Fourteen (66%) of the patients were
on ß-blocker medication.
In addition, the clinical characteristics of the twenty-six healthy
volunteers (mean age: 30 years (min-max: 15-58 years)), are also
provided in Table 1. Gender, mean age, blood pressure, heart rate
and BMI were not signiﬁcantly different between patients and volun-
teers. Patients with MFS were generally taller compared to the
healthy volunteers, which was also evident from the larger body sur-
face area.
3.1. Pulse wave velocity
Mean regional PWV-values for MFS patients and volunteers are
presented in Table 2.
In twenty-six healthy volunteers, regional PWV was determined
for ﬁve aortic segments. Of note, in three volunteers, the most distal
segment S5 (infrarenal aorta) was not included in the PWV acquisi-
tion volume due to elongation of the aorta.
In twenty-one MFS patients, a total of 102 aortic segments was eval-
uated. In three patients, S5 was not included in the PWV acquisition vol-
ume due to elongation of the aorta.Mean regional PWVwas signiﬁcantly
increased in patients with Marfan syndrome as compared to the healthy
volunteers in similar age range, in all aortic segments. However, al-
though the mean value of PWV in the ascending aorta (segment 1)Table 2
Comparison of mean PWV per aortic segment between MFS patients and healthy
volunteers.
Aortic Segment MFS patients
(n=21)
Healthy Volunteers
(n=26)
p-value
PWV S1 (m/s) 6.1±3.5 5.4±1.2 0.3
PWV S2 (m/s) 5.9±3.3 4.2±1.9 0.03
PWV S3 (m/s) 6.3±2.9 4.9±1.1 0.02
PWV S4 (m/s) 6.3±2.1 5.1±1.1 0.01
PWV S5 (m/s) 7.4±3.3 5.1±1.6 0.007
Data are presented as mean±standard deviation.
Abbreviations: MFS: Marfan syndrome; PWV: Pulse Wave Velocity; S1: ascending
aorta; S2: aortic arch; S3: thoracic descending aorta; S4: suprarenal abdominal aorta;
S5: infrarenal abdominal aorta.was higher for MFS patients as compared to healthy volunteers, these
values were not statistically signiﬁcantly different, due to the wide stan-
dard deviation.
Age-related normal PWV values were acquired from the results of
the linear regression analyses for the relation between age and region-
al PWV in the healthy volunteer cohort (Table 3). Regional PWVvalues
signiﬁcantly correlated with age (Pearson R between 0.39 and 0.57),
except for segment 2 (aortic arch) and segment 5 (infrarenal abdom-
inal aorta). In MFS patients, regional PWV at baseline was increased
when compared with age-related normal values in 17 segments
(17%) of 13 MFS patients.
3.2. Cross-sectional luminal area of the aorta
In the MFS patients, a mean aorta trajectory of 44±4 cmwas eval-
uated. For all MFS patients, mean aortic diameter measurements for
baseline and follow-up per aortic segment are provided in Table 4. Sig-
niﬁcant luminal growth at follow-up was reported in 14 out of 102
aortic segments (14%) and in 7 (33%) of the MFS patients.
3.3. Prediction of aortic luminal growth with PWV
The incidence of increased PWV per aortic segment is presented in
Table 5. For the ascending aorta (segment 1), PWV was increased in
ﬁve MFS patients, for the aortic arch (segment 2) in four MFS patients,
for the thoracic descending aorta (segment 3) in three MFS patients,
for the suprarenal abdominal aorta (segment 4) in two patients and for
the infrarenal abdominal aorta (segment 5), three patients showed in-
creased baseline PWV. The incidence of luminal increase per aortic seg-
ment is presented in Table 5. Signiﬁcant luminal growth was present in
three MFS patients for segment 1, in six patients for segment 2 and in 1
patient for segment 4. In the other segments (S3 and S5), no signiﬁcant
luminal increase was observed. Of note, two patients (S1: n=1; S2:
n=1) presented with both increased PWV at baseline and luminal in-
crease at follow-up.
Furthermore, the sensitivity, speciﬁcity and positive and negative pre-
dictive value (conﬁdence interval) for PWV predicting regional luminal
growth are presented in Table 5. Speciﬁcity of regional PWV-testing inTable 4
Aortic Diameter measurements in MFS Patients for baseline and follow-up.
Aortic Segment Baseline Follow-up p-value
Diameter S1 (mm) 27.1±2.8 27.7±3.1 0.14
Diameter S2 (mm) 22.3±2.5 23.4±2.9 0.002
Diameter S3 (mm) 20.4±2.4 20.8±2.4 0.001
Diameter S4 (mm) 18.7±2.3 19.1±2.1 0.028
Diameter S5 (mm) 14.9±1.3 15.0±1.3 0.161
Data are presented as mean±standard deviation.
Abbreviations: MFS: Marfan syndrome; S1: ascending aorta; S2: aortic arch; S3:
thoracic descending aorta; S4: suprarenal abdominal aorta; S5: infrarenal abdominal
aorta.
Table 5
Diagnostic performance of regional PWV-testing for prediction of luminal aortic growth at 2-year follow up in MFS patients.
Aortic
Segment
Incidence of
Increased
PWV
Incidence of
Luminal
Increase
Sensitivity (CI) Speciﬁcity (CI) Positive Predictive
Value (CI)
Negative
Predictive
Value (CI)
Aorta S1 5 (24%) 3 (14%) 33% (2-88%) 78% (52-93%) 20% (1-70%) 88% (60-98%)
Aorta S2 4 (19%) 6 (29%) 17% (1-64%) 80% (51-95%) 25% (1-78%) 71% (44-89%)
Aorta S3 3 (14%) 0 (0%) NA 86% (63-96%) NA 100% (78%-100%)
Aorta S4 2 (10%) 1 (5%) 0% (0%-90%) 90% (67%-98%) 0% (0-80%) 95% (72%-99%)
Aorta S5 3 (17%) 0 (0%) NA 83% (58%-96%) NA 100% (75%-100%)
Abbreviations: MFS: Marfan syndrome; S1: ascending aorta; S2: aortic arch; S3: thoracic descending aorta; S4: suprarenal abdominal aorta; S5: infrarenal abdominal aorta;
CI: conﬁdence interval; NA: not applicable.
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segments 3 and 5, sensitivity and positive predictive value are not pro-
vided, since for those segments, none of the MFS patients presented an
increased aortic luminal area at follow-up.
3.4. Intra- and inter-observer analysis
Results for intra- and inter-observer analysis for repeated image
analysis are presented in Table 6. Intra-class correlation showed ex-
cellent agreement for intra- and inter-observer analysis for both
PWV analysis as well as MRA-assessment for cross-sectional luminal
area. The variation for PWV-assessment amounted to 12% and 9%
for the MRA-assessment.
4. Discussion
In the present study, the diagnostic performance of regional PWV-
sampling with velocity-encoded MRI for prediction of aortic luminal
growth in MFS patients was evaluated. The main ﬁndings of this study
are: (i) regional PWV was increased in MFS patients as compared to
healthy volunteers in similar age range, in all aortic segments; (ii) re-
gional PWV-assessment has moderate to high speciﬁcity for predicting
absence of regional aortic luminal growth in MFS patients, as ≥78% of
the cases of without regional aortic luminal growth at 2-year follow-
up presented without increased regional PWV at baseline. Of note, re-
gional PWV-assessment lacks sensitivity, since only ≤33% of the cases
with aortic luminal growth presented with increased regional PWV at
baseline.
In patients with MFS, aortic stiffness assessment can potentially
provide complimentary prognostic value to the monitoring of the
aortic diameter for disease progression. In our study, regional aortic
stiffness at ﬁve aortic segments was expressed by PWV-assessment
from in-plane velocity-encoded MRI. When compared to age-related
normal values, the regional PWV at baseline was increased in 17% of
all studied aortic segments of these selected MFS patients. Further-
more, signiﬁcant luminal growth at follow-up was reported in 14%
of the aortic segments. Of note, the diagnostic performance of region-
al PWV-testing for prediction of regional aortic luminal growth at
2-year follow-up showed moderate to high speciﬁcity for all aortic
segments.Table 6
Intra- and inter-observer analysis for both PWV analyses as MRA-assessment for cross-sect
Intra-observer
PWV MRA
Intra-class correlation 0.90 (pb0.001) 0.96 (
Mean difference±SD 0.09±0.64 (m/s) 3±25
95% CI (m/s) −0.2−0.4 m/s −8−
p-value t-test 0.54 0.59
Coefﬁcient of variation 12% 9%
Abbreviations: PWV: pulse wave velocity; MRA: magnetic resonance angiography; 95% CI:To our knowledge, the predictive value of regional aortic stiffness,
described by PWV for luminal aortic growth in MFS patients, has not
been reported before. In a previous study by Nollen et al. in 78
non-operated MFS patients, the predictive value of aortic stiffness
both locally by distensibility assessment at a single position and re-
gionally by PWV-assessment from through-plane velocity-encoded
MRI was investigated for patients with progressive aortic dilatation
[10]. Aortic stiffness, calculated at a local level by distensibility was
an independent predictor of progressive descending thoracic aortic
dilatation. However, in the same study, the authors reported that
PWV from through-plane VE MRI did not hold predictive value for
aortic luminal growth in the descending thoracic aorta. This fact
may possibly be explained by the limited accuracy due to the low
temporal resolution (i.e. 25 ms) of the MRI-sequence that was used
by Nollen et al. A temporal resolution of 25 ms is low considering
the transit-time between ﬂow waves at ascending and proximal de-
scending aorta is in the order of 20 ms. In comparison, we used a tem-
poral resolution of 8.6 ms. Furthermore, they used the half-peak of the
ﬂowwave as deﬁnition of pulse wave arrival, whereas in our study the
foot of the velocity wave was used, a deﬁnition that should be more
robust when automated transit-time assessment is less corrupted by
early wave reﬂections and not affected by distal damping of the
wave front [17].
A previous study showed that regional PWV-assessment from
in-plane VE MRI with high temporal resolution (i.e. 8.6 ms) shows
higher agreement with invasive pressure measurements, the true gold
standard for PWV-assessment [13], than PWV-assessment from
through-plane VE MRI. Furthermore, regional aortic stiffness assess-
ment with in-plane VE MRI at 200 sampling positions along the aorta
centerline may be more sensitive in detecting regional stiffness varia-
tion. Of note, performing multiple local aortic stiffness assessment by
distensibility calculations from maximal and minimal cross-sectional
lumen area at 200 positions over the total aortic length is impracticable
with respect of the extensive MRI planning and elaborate post-
processing, and the local pulse pressure, which is required for distensibil-
ity calculations, may only be accurately assessed invasively. On the other
hand, local PWV-assessment from in-plane VE MRI is feasible in terms of
scan duration and post-processing time.
Groenink et al. showed that PWV from though-plane VE MRI was
increased in MFS patients as compared to a control group withional luminal area.
Inter-observer
PWV MRA
pb0.001) 0.96 (pb0.001) 0.99 (pb0.001)
mm2 0.12±0.70 m/s −3±9 mm2
14 mm2 −0.2−0.4 m/s −7−1 mm2
0.46 0.22
13% 3%
95% conﬁdence interval.
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segments of the aorta (ascending aorta-aortic arch, thoracic descend-
ing aorta and abdominal descending aorta) [6]. Similar to that study,
we found that PWV was increased in MFS patients as compared to
healthy volunteers in all aortic segments. However, for the ascending
aorta (segment 1) the difference in mean PWV between MFS patients
and volunteers was not statistically signiﬁcant. This ﬁnding may be
explained by the fact that MFS patients in this study cohort can be
considered as relatively healthy (i.e., well regulated by medical treat-
ment) since aortic surgery was not indicated yet for these patients at
the time of study and MFS has a variable manifestation of disease. In
addition, MRI in the ascending aorta is prone to respiratory blurring
and movement of the aorta during the cardiac cycle, more than in
other parts of the aorta. This might have reduced accuracy in this
part of the aorta, both for MRA as well as PWV-assessment.
In adult MFS patients, current guidelines for prophylactic replace-
ment of aortic root include excessive aortic growth, deﬁned as growth
of the aortic diameter of ≥5 mm/year [6,18]. In our study, we used
the deﬁnition of signiﬁcant luminal increase of >2 mm diameter
growth at 2-year follow-up. Using this deﬁnition, 10 (14%) of the
evaluated aortic segments showed signiﬁcant luminal increase. In
total, 7 patients (33%) presented with signiﬁcant luminal growth in
at least one aortic segment.
Some MFS patients experience acute dissections even in the pres-
ence of non- or moderately-dilated aortas [6]. Therefore, next to apply-
ing the current clinical guidelines, also monitoring of the entire aortic
diameter with respect to other risk factors for aortic dissection, such as
aortic stiffness, may prove to hold predictive value for disease progres-
sion [10,11,19]. In our study, at least 78% of the cases without regional
aortic luminal growth at follow-up presented without increased region-
al PWV at baseline. Therefore, regional PWV-assessment by VE MRI has
moderate to high speciﬁcity for all aortic segments in these MFS pa-
tients. This ﬁnding implies that regional PWV-assessment is good at
demonstrating absence of progressive disease. In contrast, 33% or less
of the cases which presented with increased regional PWV at baseline
revealed regional aortic luminal growth at follow-up. This ﬁnding im-
plies that regional PWV-assessment lack sensitivity as it seemsmarginal
at detecting present disease. Consequently, the risk-stratiﬁcation strate-
gy presented (i.e., regional PWV-testing) can be used to rule out progres-
sive disease, which potentially is very useful for managing patients.
Therefore, regional PWV-testing may potentially be useful complimenta-
ry to other clinical parameters, i.e. aortic diameter assessment.
A potential limitation of our study is the selection of a relatively
healthy population of MFS patients (which had not yet undergone
elective aortic surgery at the time of study) and the short follow-up
duration. By evaluating these selective patients during a longer
follow-up duration, more patients might reveal progressive aortic di-
latation. Typically studies show differences between healthy volun-
teers and very abnormals. The near normals (relatively healthy MFS
patients) described in the present study represent a tougher cohort
where imaging can be really of beneﬁt. However, we need to ac-
knowledge that our present ﬁndings are based on a relatively small
study population and need to be validated in a larger and more chal-
lenging study population. Furthermore, since the healthy volunteers
did not undergo a CE-MRA acquisition and no follow-up MRI exami-
nation, analysis between MFS patients and healthy volunteers was
not performed blinded. However, analysis of MFS patients with re-
spect to the patient characteristics was blinded. In addition, aortic
segments for the PWV-analysis and the CE-MRA analysis were co-
registered by the aortic centerline. Only after this image analysis
was completed, results for PWV and CE-MRA analyses were com-
bined. Of note, MRA aortic centerline detection is semi-automated
[15]. Importantly, for PWV analysis, the arrival time of each of the
200 wave forms was automatically determined as previously de-
scribed [13]. Of note, accuracy of regional PWV-assessment maydepend on the segment length, since including a longer trajectory
with more sampling points may result in more accurate weighting
of the pulse wave transit-time over this particular segment. In addi-
tion, the curvature of the proximal aorta and the motion during the
cardiac cycle that the proximal aorta is subjected to as compared to
the more distal aorta is potentially an additional source of error, as
well as the presence of branches that may lead to early wave reﬂec-
tions that can corrupt the automated deﬁnition of the foot of the
pulse wave.
5. Conclusion
Regional PWV was signiﬁcantly increased in selected MFS patients
as compared to healthy volunteers within similar age range, in all aortic
segments except in the ascending aorta. Furthermore, regional
PWV-assessment has moderate to high speciﬁcity in MFS patients, as
≥78% of the cases without regional aortic luminal growth at 2-year
follow-up presented without increased regional PWV at baseline.
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